+1 347 708 0418
Report Summary
Immuno-oncology Drugs-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Immuno-oncology Drugs industry, standing on the readers perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Immuno-oncology Drugs 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Immuno-oncology Drugs worldwide, with company and product introduction, position in the Immuno-oncology Drugs market
Market status and development trend of Immuno-oncology Drugs by types and applications
Cost and profit status of Immuno-oncology Drugs, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Immuno-oncology Drugs market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Immuno-oncology Drugs industry.
The report segments the global Immuno-oncology Drugs market as:
Global Immuno-oncology Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Immuno-oncology Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
Global Immuno-oncology Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Global Immuno-oncology Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Immuno-oncology Drugs Sales Volume, Revenue, Price and Gross Margin):
Amgen, Inc
Johnson & Johnson
Celgene Corporation
AstraZeneca, Plc
Hoffmann-La Roche AG
Bristol-Myers Squibb
AbbVie, Inc.
Merck & Co.
Eli Lilly and Company
Novartis International AG
Prometheus Therapeutics & Diagnostics
Bavarian Nordic
Pfizer Inc.
ImmunoCellular Therapeutics
Aduro BioTech
Gilead Sciences Inc.
Sanofi S.A.
Celldex Therapeutics
Galena Biopharma
EMD Serono, Inc.
Bio-Rad Laboratories, Inc.
Incyte
Lonza Group
Enzo Biochem, Inc.
Spring Bank Pharmaceuticals, Inc.
Agenus Inc.
Ferring Pharmaceuticals
Dendreon Corporation
Avantor, Inc.
Agilent Technologies Inc
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
Chapter 1 Overview of Immuno-oncology Drugs
1.1 Definition of Immuno-oncology Drugs in This Report
1.2 Commercial Types of Immuno-oncology Drugs
1.2.1 Immune Checkpoint Inhibitors
1.2.2 Immune System Modulators
1.2.3 Cancer Vaccines
1.2.4 Oncolytic Virus
1.2.5 Others
1.3 Downstream Application of Immuno-oncology Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Development History of Immuno-oncology Drugs
1.5 Market Status and Trend of Immuno-oncology Drugs 2015-2026
1.5.1 Global Immuno-oncology Drugs Market Status and Trend 2015-2026
1.5.2 Regional Immuno-oncology Drugs Market Status and Trend 2015-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Immuno-oncology Drugs 2015-2019
2.2 Production Market of Immuno-oncology Drugs by Regions
2.2.1 Production Volume of Immuno-oncology Drugs by Regions
2.2.2 Production Value of Immuno-oncology Drugs by Regions
2.3 Demand Market of Immuno-oncology Drugs by Regions
2.4 Production and Demand Status of Immuno-oncology Drugs by Regions
2.4.1 Production and Demand Status of Immuno-oncology Drugs by Regions 2015-2019
2.4.2 Import and Export Status of Immuno-oncology Drugs by Regions 2015-2019
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Immuno-oncology Drugs by Types
3.2 Production Value of Immuno-oncology Drugs by Types
3.3 Market Forecast of Immuno-oncology Drugs by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Immuno-oncology Drugs by Downstream Industry
4.2 Market Forecast of Immuno-oncology Drugs by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Immuno-oncology Drugs
5.1 Global Economy Situation and Trend Overview
5.2 Immuno-oncology Drugs Downstream Industry Situation and Trend Overview
Chapter 6 Immuno-oncology Drugs Market Competition Status by Major Manufacturers
6.1 Production Volume of Immuno-oncology Drugs by Major Manufacturers
6.2 Production Value of Immuno-oncology Drugs by Major Manufacturers
6.3 Basic Information of Immuno-oncology Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Immuno-oncology Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Immuno-oncology Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Immuno-oncology Drugs Major Manufacturers Introduction and Market Data
7.1 Amgen, Inc
7.1.1 Company profile
7.1.2 Representative Immuno-oncology Drugs Product
7.1.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc
7.2 Johnson & Johnson
7.2.1 Company profile
7.2.2 Representative Immuno-oncology Drugs Product
7.2.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.3 Celgene Corporation
7.3.1 Company profile
7.3.2 Representative Immuno-oncology Drugs Product
7.3.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Celgene Corporation
7.4 AstraZeneca, Plc
7.4.1 Company profile
7.4.2 Representative Immuno-oncology Drugs Product
7.4.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca, Plc
7.5 Hoffmann-La Roche AG
7.5.1 Company profile
7.5.2 Representative Immuno-oncology Drugs Product
7.5.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche AG
7.6 Bristol-Myers Squibb
7.6.1 Company profile
7.6.2 Representative Immuno-oncology Drugs Product
7.6.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.7 AbbVie, Inc.
7.7.1 Company profile
7.7.2 Representative Immuno-oncology Drugs Product
7.7.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AbbVie, Inc.
7.8 Merck & Co.
7.8.1 Company profile
7.8.2 Representative Immuno-oncology Drugs Product
7.8.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Merck & Co.
7.9 Eli Lilly and Company
7.9.1 Company profile
7.9.2 Representative Immuno-oncology Drugs Product
7.9.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company
7.10 Novartis International AG
7.10.1 Company profile
7.10.2 Representative Immuno-oncology Drugs Product
7.10.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Novartis International AG
7.11 Prometheus Therapeutics & Diagnostics
7.11.1 Company profile
7.11.2 Representative Immuno-oncology Drugs Product
7.11.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Prometheus Therapeutics & Diagnostics
7.12 Bavarian Nordic
7.12.1 Company profile
7.12.2 Representative Immuno-oncology Drugs Product
7.12.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bavarian Nordic
7.13 Pfizer Inc.
7.13.1 Company profile
7.13.2 Representative Immuno-oncology Drugs Product
7.13.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc.
7.14 ImmunoCellular Therapeutics
7.14.1 Company profile
7.14.2 Representative Immuno-oncology Drugs Product
7.14.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of ImmunoCellular Therapeutics
7.15 Aduro BioTech
7.15.1 Company profile
7.15.2 Representative Immuno-oncology Drugs Product
7.15.3 Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Aduro BioTech
7.16 Gilead Sciences Inc.
7.17 Sanofi S.A.
7.18 Celldex Therapeutics
7.19 Galena Biopharma
7.20 EMD Serono, Inc.
7.21 Bio-Rad Laboratories, Inc.
7.22 Incyte
7.23 Lonza Group
7.24 Enzo Biochem, Inc.
7.25 Spring Bank Pharmaceuticals, Inc.
7.26 Agenus Inc.
7.27 Ferring Pharmaceuticals
7.28 Dendreon Corporation
7.29 Avantor, Inc.
7.30 Agilent Technologies Inc
Chapter 8 Upstream and Downstream Market Analysis of Immuno-oncology Drugs
8.1 Industry Chain of Immuno-oncology Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Immuno-oncology Drugs
9.1 Cost Structure Analysis of Immuno-oncology Drugs
9.2 Raw Materials Cost Analysis of Immuno-oncology Drugs
9.3 Labor Cost Analysis of Immuno-oncology Drugs
9.4 Manufacturing Expenses Analysis of Immuno-oncology Drugs
Chapter 10 Marketing Status Analysis of Immuno-oncology Drugs
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
List of Tables
Table Advantage and Disadvantage of Immune Checkpoint Inhibitors
Table Advantage and Disadvantage of Immune System Modulators
Table Advantage and Disadvantage of Cancer Vaccines
Table Advantage and Disadvantage of Oncolytic Virus
Table Advantage and Disadvantage of Others
Table Production Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Production Value of Immuno-oncology Drugs by Regions 2015-2019
Table Demand Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Production and Demand Status of Immuno-oncology Drugs in Region One 2015-2019
Table Production and Demand Status of Immuno-oncology Drugs in Region Two 2015-2019
Table Production and Demand Status of Immuno-oncology Drugs in Region Three 2015-2019
Table Production and Demand Status of Immuno-oncology Drugs in Region Four 2015-2019
Table Import Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Export Volume of Immuno-oncology Drugs by Regions 2015-2019
Table Production Volume of Immuno-oncology Drugs by Types 2015-2019
Table Production Value of Immuno-oncology Drugs by Types 2015-2019
Table Production Volume Forecast of Immuno-oncology Drugs by Types 2020-2026
Table Production Value Forecast of Immuno-oncology Drugs by Types 2020-2026
Table Demand Volume of Immuno-oncology Drugs by Downstream Industry 2015-2019
Table Demand Volume Forecast of Immuno-oncology Drugs by Downstream Industry 2020-2026
Table Production Volume of Immuno-oncology Drugs by Major Manufacturers 2015-2019
Table Production Value of Immuno-oncology Drugs by Major Manufacturers 2015-2019
Table Headquarters Location and Established Time of Immuno-oncology Drugs Major Manufacturer
Table Employees and Revenue Level of Immuno-oncology Drugs Major Manufacturer
Table Representative Immuno-oncology Drugs Product One of Amgen, Inc
Table Representative Immuno-oncology Drugs Product Two of Amgen, Inc
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Amgen, Inc 2015-2019
Table Representative Immuno-oncology Drugs Product One of Johnson & Johnson
Table Representative Immuno-oncology Drugs Product Two of Johnson & Johnson
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson 2015-2019
Table Representative Immuno-oncology Drugs Product One of Celgene Corporation
Table Representative Immuno-oncology Drugs Product Two of Celgene Corporation
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Celgene Corporation 2015-2019
Table Representative Immuno-oncology Drugs Product One of AstraZeneca, Plc
Table Representative Immuno-oncology Drugs Product Two of AstraZeneca, Plc
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AstraZeneca, Plc 2015-2019
Table Representative Immuno-oncology Drugs Product One of Hoffmann-La Roche AG
Table Representative Immuno-oncology Drugs Product Two of Hoffmann-La Roche AG
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche AG 2015-2019
Table Representative Immuno-oncology Drugs Product One of Bristol-Myers Squibb
Table Representative Immuno-oncology Drugs Product Two of Bristol-Myers Squibb
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb 2015-2019
Table Representative Immuno-oncology Drugs Product One of AbbVie, Inc.
Table Representative Immuno-oncology Drugs Product Two of AbbVie, Inc.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of AbbVie, Inc. 2015-2019
Table Representative Immuno-oncology Drugs Product One of Merck & Co.
Table Representative Immuno-oncology Drugs Product Two of Merck & Co.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Merck & Co. 2015-2019
Table Representative Immuno-oncology Drugs Product One of Eli Lilly and Company
Table Representative Immuno-oncology Drugs Product Two of Eli Lilly and Company
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly and Company 2015-2019
Table Representative Immuno-oncology Drugs Product One of Novartis International AG
Table Representative Immuno-oncology Drugs Product Two of Novartis International AG
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Novartis International AG 2015-2019
Table Representative Immuno-oncology Drugs Product One of Prometheus Therapeutics & Diagnostics
Table Representative Immuno-oncology Drugs Product Two of Prometheus Therapeutics & Diagnostics
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Prometheus Therapeutics & Diagnostics 2015-2019
Table Representative Immuno-oncology Drugs Product One of Bavarian Nordic
Table Representative Immuno-oncology Drugs Product Two of Bavarian Nordic
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Bavarian Nordic 2015-2019
Table Representative Immuno-oncology Drugs Product One of Pfizer Inc.
Table Representative Immuno-oncology Drugs Product Two of Pfizer Inc.
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc. 2015-2019
Table Representative Immuno-oncology Drugs Product One of ImmunoCellular Therapeutics
Table Representative Immuno-oncology Drugs Product Two of ImmunoCellular Therapeutics
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of ImmunoCellular Therapeutics 2015-2019
Table Representative Immuno-oncology Drugs Product One of Aduro BioTech
Table Representative Immuno-oncology Drugs Product Two of Aduro BioTech
Table Immuno-oncology Drugs Sales, Revenue, Price and Gross Margin of Aduro BioTech 2015-2019
List of Figures
Figure Representative Commercial Product Picture of Immuno-oncology Drugs
Figure Global Shipments Volume Share of Immuno-oncology Drugs by Types in 2019
Figure Representative Commercial Product Picture of Immune Checkpoint Inhibitors
Figure Representative Commercial Product Picture of Immune System Modulators
Figure Representative Commercial Product Picture of Cancer Vaccines
Figure Representative Commercial Product Picture of Oncolytic Virus
Figure Representative Commercial Product Picture of Others
Figure Demand Volume Share of Immuno-oncology Drugs by Downstream Industry in 2019
Figure Hospitals Examples of Immuno-oncology Drugs
Figure Clinics Examples of Immuno-oncology Drugs
Figure Ambulatory Surgical Centers Examples of Immuno-oncology Drugs
Figure Global Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Global Immuno-oncology Drugs Market Size Comparison in 2015, 2019 and 2026
Figure North America Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Europe Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure China Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Japan Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Rest APAC Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Latin America Immuno-oncology Drugs Revenue and Growth Rate 2015-2026
Figure Production Volume and Growth Rate of Immuno-oncology Drugs 2015-2019
Figure Production Value and Growth Rate of Immuno-oncology Drugs 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Regions in 2015
Figure Production Volume Share of Immuno-oncology Drugs by Regions in 2019
Figure Production Volume Growth Rate Comparison of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Value Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Value Share of Immuno-oncology Drugs by Regions in 2015
Figure Production Value Share of Immuno-oncology Drugs by Regions in 2019
Figure Production Value Growth Rate Comparison of Immuno-oncology Drugs by Regions 2015-2019
Figure Demand Volume Share of Immuno-oncology Drugs by Regions 2015-2019
Figure Demand Volume Share of Immuno-oncology Drugs by Regions in 2015
Figure Demand Volume Share of Immuno-oncology Drugs by Regions in 2019
Figure Demand Volume Growth Rate Comparison of Immuno-oncology Drugs by Regions 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Types 2015-2019
Figure Production Volume Share of Immuno-oncology Drugs by Types in 2015
Figure Production Volume Share of Immuno-oncology Drugs by Types in 2019
Figure Production Volume Growth Rate Comparison of Immuno-oncology Drugs by Types 2015-2019
Figure Production Value Share of Immuno-oncology Drugs by Types 2015-2019
Figure Production Value Share of Immuno-oncology Drugs by Types in 2015
Figure Production Value Share of Immuno-oncology Drugs by Types in 2019
Figure Production Value Growth Rate Comparison of Immuno-oncology Drugs by Types 2015-2019
Figure Production Volume Share Forecast of Immuno-oncology Drugs by Types in 2026
Figure Production Value Share Forecast of Immuno-oncology Drugs by Types in 2026
Figure Demand Volume Share of Immuno-oncology Drugs by Downstream Industry 2015-2019
Figure Demand Volume Share of Immuno-oncology Drugs by Downstream Industry in 2015
Figure Demand Volume Share of Immuno-oncology Drugs by Downstream Industry in 2019
Figure Demand Volume Growth Rate Comparison of Immuno-oncology Drugs by Downstream Industry 2015-2019
Figure Demand Volume Share Forecast of Immuno-oncology Drugs by Downstream Industry in 2026
Figure Production Volume Share of Immuno-oncology Drugs by Major Manufacturers in 2015
Figure Production Volume Share of Immuno-oncology Drugs by Major Manufacturers in 2019
Figure Production Value Share of Immuno-oncology Drugs by Major Manufacturers in 2015
Figure Production Value Share of Immuno-oncology Drugs by Major Manufacturers in 2019
Figure Immuno-oncology Drugs Revenue and Market Share of Amgen, Inc 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Johnson & Johnson 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Celgene Corporation 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of AstraZeneca, Plc 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Hoffmann-La Roche AG 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Bristol-Myers Squibb 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of AbbVie, Inc. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Merck & Co. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Eli Lilly and Company 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Novartis International AG 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Prometheus Therapeutics & Diagnostics 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Bavarian Nordic 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of Pfizer Inc. 2015-2019
Figure Immuno-oncology Drugs Revenue and Market Share of ImmunoCellular Therapeutics 2015-2019
Buy
